CL
BMRN icon

Choreo LLC’s BioMarin Pharmaceuticals BMRN Stock Holding History

Choreo LLC’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$592K Buy
10,482
+5,181
+98% +$302K 0.01% 848
2025
Q4 		$313K Sell
5,301
-1,566
-23% -$85.3K ﹤0.01% 1193
2025
Q3 		$372K Sell
6,867
-406
-6% -$23.2K ﹤0.01% 1098
2025
Q2 		$400K Buy
7,273
+464
+7% +$27.3K 0.01% 1015
2025
Q1 		$481K Sell
6,809
-3,225
-32% -$217K 0.01% 853
2024
Q4 		$657K Sell
10,034
-214
-2% -$14.3K 0.01% 761
2024
Q3 		$718K Buy
10,248
+1,572
+18% +$131K 0.01% 721
2024
Q2 		$713K Buy
+8,676
New +$722K 0.01% 656

Other funds holding BMRN

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return